VPI-121

N/A

Report date: 2025/01/26 17:27:18

Base Information

Drug NameVPI-121
Drug Alias NameGP100-VaultVPI-121
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Therapeutic vaccine
Mechanisms of ActionMelanocyte protein PMEL stimulants
TargetsMelanocyte protein PMEL
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesVault Pharma Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A